Healthcare provider profile · identity verified

Deborah Sperry, N.P.

Nurse Practitioner · BLOOMFIELD HILLS, MI · NPI 1386179885

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	438	144
Furosemide	Furosemide	353	102
Gabapentin	Gabapentin	306	92
Levothyroxine Sodium	Levothyroxine Sodium	253	95
Amlodipine Besylate	Amlodipine Besylate	236	80
Eliquis	Apixaban	211	76
Pantoprazole Sodium	Pantoprazole Sodium	205	68
Metoprolol Succinate	Metoprolol Succinate	192	72
Losartan Potassium	Losartan Potassium	165	68
Mirtazapine	Mirtazapine	163	36
Lisinopril	Lisinopril	158	50
Tamsulosin Hcl	Tamsulosin Hcl	158	59
Oxycodone Hcl	Oxycodone Hcl	155	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	141	64
Quetiapine Fumarate	Quetiapine Fumarate	136	35
Omeprazole	Omeprazole	120	45
Potassium Chloride	Potassium Chloride	120	35
Pregabalin	Pregabalin	120	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	115	29
Escitalopram Oxalate	Escitalopram Oxalate	110	30
Donepezil Hcl	Donepezil Hcl	108	31
Carvedilol	Carvedilol	106	36
Methocarbamol	Methocarbamol	100	40
Metoprolol Tartrate	Metoprolol Tartrate	100	44
Sertraline Hcl	Sertraline Hcl	97	30
Alprazolam	Alprazolam	96	39
Xarelto	Rivaroxaban	96	15
Metformin Hcl	Metformin Hcl	95	35
Hydralazine Hcl	Hydralazine Hcl	93	33
Tramadol Hcl	Tramadol Hcl	81	47
Trazodone Hcl	Trazodone Hcl	80	28
Warfarin Sodium	Warfarin Sodium	75	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	72	12
Baclofen	Baclofen	68	18
Levetiracetam	Levetiracetam	66	17
Clopidogrel	Clopidogrel Bisulfate	65	40
Simvastatin	Simvastatin	62	19
Prednisone	Prednisone	61	27
Lorazepam	Lorazepam	60	19
Duloxetine Hcl	Duloxetine Hcl	59	22
Buspirone Hcl	Buspirone Hcl	57	16
Memantine Hcl	Memantine Hcl	53	15
Ezetimibe	Ezetimibe	52	19
Olanzapine	Olanzapine	52	11
Midodrine Hcl	Midodrine Hcl	51	25
Cephalexin	Cephalexin	48	34
Jardiance	Empagliflozin	47	21
Amiodarone Hcl	Amiodarone Hcl	43	18
Methenamine Hippurate	Methenamine Hippurate	43	12
Famotidine	Famotidine	40	11
Divalproex Sodium	Divalproex Sodium	39	suppressed
Montelukast Sodium	Montelukast Sodium	39	15
Albuterol Sulfate Hfa	Albuterol Sulfate	38	35
Spironolactone	Spironolactone	37	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	13
Entresto	Sacubitril/Valsartan	34	11
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	13
Gemtesa	Vibegron	32	suppressed
Allopurinol	Allopurinol	31	13
Januvia	Sitagliptin Phosphate	31	15
Loperamide	Loperamide Hcl	31	20
Novolog Flexpen	Insulin Aspart	31	suppressed
Celecoxib	Celecoxib	29	suppressed
Fentanyl	Fentanyl	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	28	13
Ketoconazole	Ketoconazole	28	suppressed
Ondansetron Odt	Ondansetron	28	26
Modafinil	Modafinil	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Atenolol	Atenolol	25	suppressed
Finasteride	Finasteride	25	17
Bumetanide	Bumetanide	24	16
Bupropion Xl	Bupropion Hcl	24	12
Nitroglycerin	Nitroglycerin	24	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	20
Clonazepam	Clonazepam	23	12
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Nystatin	Nystatin	23	13
Myrbetriq	Mirabegron	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	20
Calcitriol	Calcitriol	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	14
Nifedipine Er	Nifedipine	20	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	12
Ibuprofen	Ibuprofen	19	suppressed
Meloxicam	Meloxicam	19	11
Metformin Hcl Er	Metformin Hcl	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	11
Aripiprazole	Aripiprazole	18	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	12
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Oxcarbazepine	Oxcarbazepine	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Digoxin	Digoxin	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	11
Diazepam	Diazepam	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Glipizide Er	Glipizide	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Latanoprost	Latanoprost	13	12
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Single Use Swab	Alcohol Antiseptic Pads	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lithium Carbonate Er	Lithium Carbonate	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Rexulti	Brexpiprazole	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Fluconazole	Fluconazole	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Lagevrio (Eua)	Molnupiravir	11	11
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Temazepam	Temazepam	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error